Published in Int J Cancer on April 25, 2011
'TXT2BFiT' a mobile phone-based healthy lifestyle program for preventing unhealthy weight gain in young adults: study protocol for a randomized controlled trial. Trials (2013) 1.09
Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol (2012) 0.95
Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia. Carcinogenesis (2014) 0.93
Trajectory of body shape across the lifespan and cancer risk. Int J Cancer (2016) 0.93
Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality. Int J Cancer (2014) 0.92
Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype. Am J Epidemiol (2013) 0.83
Body Mass Index Genetic Risk Score and Endometrial Cancer Risk. PLoS One (2015) 0.81
Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer. Oncotarget (2016) 0.81
Joint Effect of Genotypic and Phenotypic Features of Reproductive Factors on Endometrial Cancer Risk. Sci Rep (2015) 0.76
Physical activity in young adults: a signal detection analysis of Health Information National Trends Survey (HINTS) 2007 data. J Health Commun (2014) 0.75
Breakfast Protein Source Does Not Influence Postprandial Appetite Response and Food Intake in Normal Weight and Overweight Young Women. J Nutr Metab (2016) 0.75
Analysis of endometrial thickness measured by transvaginal ultrasonography in obese patients. Einstein (Sao Paulo) (2014) 0.75
Disease risk estimation by combining case-control data with aggregated information on the population at risk. Biometrics (2014) 0.75
Body size over the life-course and the risk of endometrial cancer: the California Teachers Study. Cancer Causes Control (2016) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer (1985) 3.50
Obesity and cancer. Oncogene (2004) 3.01
Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control (1998) 2.05
The epidemiology of endometrial cancer. Gynecol Oncol (1991) 1.94
Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res (1997) 1.91
Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev (2001) 1.91
Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol (2001) 1.90
Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer (2003) 1.71
Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst (2004) 1.60
Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol (2005) 1.58
Epidemiology of endometrial cancer. J Natl Cancer Inst (1977) 1.50
Diet and cancer. Oncologist (2000) 1.48
Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control (2007) 1.48
Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst (1999) 1.47
Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev (2007) 1.39
Prevention of cancers of the breast, endometrium and ovary. Oncogene (2004) 1.31
Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer (2005) 1.29
Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control (1999) 1.28
Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol (2005) 1.25
Obesity as a risk factor for certain types of cancer. Lipids (1998) 1.20
Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int J Cancer (2010) 1.19
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications. Am J Obstet Gynecol (1981) 1.01
Physical activity and risk of endometrial cancer: a report from the Shanghai endometrial cancer study. Cancer Epidemiol Biomarkers Prev (2005) 1.00
Peripheral aromatization as a risk factor for breast and endometrial cancer in postmenopausal women: a review. Gynecol Oncol (1984) 0.95
The effects of progesterone and progestins on endometrial proliferation. Contraception (1998) 0.86
Longitudinal study on birthweight and the incidence of endometrial cancer. Br J Cancer (2008) 0.80
Progestin regulation of human endometrial function. Hum Reprod (2000) 0.80
Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT. J Reprod Med (1999) 0.78
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Ambra1 regulates autophagy and development of the nervous system. Nature (2007) 6.94
Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res (2008) 6.47
American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc (2010) 6.18
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Myelodysplastic syndromes: incidence and survival in the United States. Cancer (2007) 3.89
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 3.73
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle (2009) 3.60
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A (2005) 3.22
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res (2006) 3.21
PPM1D mutations in circulating white blood cells and the risk for ovarian cancer. J Natl Cancer Inst (2013) 3.15
Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07
Physicians' weight loss counseling in two public hospital primary care clinics. Acad Med (2004) 2.94
IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab (2012) 2.75
Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev (2009) 2.73
Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst (2006) 2.48
Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res (2007) 2.45
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res (2008) 2.24
Molecular markers and death from prostate cancer. Ann Intern Med (2009) 2.15
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res (2010) 2.15
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med (2005) 2.06
IGF-I and breast cancer: a meta-analysis. Int J Cancer (2004) 2.03
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev (2008) 2.01
Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol (2010) 2.00
Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause (2004) 1.97
Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst (2013) 1.96
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat (2008) 1.86
The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know. J Am Diet Assoc (2011) 1.80
The Healthy Eating Index 2005 and risk for pancreatic cancer in the NIH-AARP study. J Natl Cancer Inst (2013) 1.75
Exercise effect on weight and body fat in men and women. Obesity (Silver Spring) (2007) 1.68
The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer (2005) 1.67
Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells. Oncogene (2003) 1.65
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res (2011) 1.64
Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat (2012) 1.60
Comparison of energy expenditure estimates from doubly labeled water, a physical activity questionnaire, and physical activity records. Am J Clin Nutr (2002) 1.59
Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. Am J Epidemiol (2015) 1.58
ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst (2010) 1.54
Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings. Cancer Epidemiol Biomarkers Prev (2004) 1.49
Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst (2007) 1.49
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Prevalence of overweight, obesity, and associated diseases among outpatients in a public hospital. South Med J (2003) 1.44
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. Heart Rhythm (2011) 1.43
Women's choice between sentinel lymph node biopsy and axillary clearance. ANZ J Surg (2002) 1.42
Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity (Silver Spring) (2009) 1.41
Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur J Cancer (2009) 1.41
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol (2005) 1.40
Association between Echinococcus granulosus infection and cancer risk - a pilot study in Cyprus. Clin Chem Lab Med (2016) 1.39
Vitamin D and prevention of cancer--ready for prime time? N Engl J Med (2011) 1.38
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol (2007) 1.37
Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res (2005) 1.37
Associations of ethnicity/race and socioeconomic status with early childhood caries patterns. J Public Health Dent (2006) 1.36
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One (2013) 1.33
Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 1.30
Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysis. J Cancer Surviv (2007) 1.27
Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer (2006) 1.27
Race/ethnicity, physical activity, and quality of life in breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2009) 1.27
Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol (2002) 1.27
The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design. Cancer Causes Control (2013) 1.26
Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control (2012) 1.26
Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol (2011) 1.26
Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control (2011) 1.25
Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2010) 1.25
Prevalence of polycythemia vera and essential thrombocythemia. Am J Hematol (2008) 1.24
Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Cancer (2006) 1.24
Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep (2003) 1.23
Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol (2003) 1.22
Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials. Psychooncology (2009) 1.21
Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol (2005) 1.21
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis (2012) 1.20
Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncol Res (2004) 1.20
Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women. Cancer Res (2003) 1.19
Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers. Psychooncology (2009) 1.19
Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx. Cancer Epidemiol Biomarkers Prev (2009) 1.19
Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma. J Invest Dermatol (2011) 1.19